SHSE:600161 (China)
Â
Class A
Â¥
31.19
(-0.38%)
Jun 7
Current and historical daily PE Ratio for Beijing Tiantan Biological Products Corp Ltd (
SHSE:600161
) from 1998 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Beijing Tiantan Biological Products stock (SHSE:600161) PE ratio as of Jun 09 2024 is 44.56.
More Details
Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) PE Ratio (TTM) Chart
Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) PE Ratio (TTM) Historical Data
View and export this data going back to 1998. Start your Free Trial
Total 1206
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Beijing Tiantan Biological Products PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 44.6 | 2024-04-05 | 38.6 |
| 2024-06-07 | 44.6 | 2024-04-03 | 38.6 |
| 2024-06-06 | 44.7 | 2024-04-02 | 38.0 |
| 2024-06-05 | 43.9 | 2024-04-01 | 38.3 |
| 2024-06-04 | 43.2 | 2024-03-29 | 38.6 |
| 2024-06-03 | 43.0 | 2024-03-28 | 36.4 |
| 2024-05-31 | 40.5 | 2024-03-27 | 38.8 |
| 2024-05-30 | 40.5 | 2024-03-26 | 39.0 |
| 2024-05-29 | 40.3 | 2024-03-25 | 38.8 |
| 2024-05-28 | 40.0 | 2024-03-22 | 39.1 |
| 2024-05-27 | 41.2 | 2024-03-21 | 39.7 |
| 2024-05-24 | 40.7 | 2024-03-20 | 40.4 |
| 2024-05-23 | 40.7 | 2024-03-19 | 40.5 |
| 2024-05-22 | 40.4 | 2024-03-18 | 42.2 |
| 2024-05-21 | 40.9 | 2024-03-15 | 42.4 |
| 2024-05-20 | 41.6 | 2024-03-14 | 42.0 |
| 2024-05-17 | 41.0 | 2024-03-13 | 42.0 |
| 2024-05-16 | 41.9 | 2024-03-12 | 42.2 |
| 2024-05-15 | 42.7 | 2024-03-11 | 41.9 |
| 2024-05-14 | 43.5 | 2024-03-08 | 40.8 |
| 2024-05-13 | 43.1 | 2024-03-07 | 40.5 |
| 2024-05-10 | 43.2 | 2024-03-06 | 41.8 |
| 2024-05-09 | 43.4 | 2024-03-05 | 41.6 |
| 2024-05-08 | 42.9 | 2024-03-04 | 41.6 |
| 2024-05-07 | 42.7 | 2024-03-01 | 41.7 |
| 2024-05-06 | 42.3 | 2024-02-29 | 42.2 |
| 2024-05-03 | 41.1 | 2024-02-28 | 41.2 |
| 2024-05-02 | 41.1 | 2024-02-27 | 41.3 |
| 2024-04-30 | 41.1 | 2024-02-26 | 40.7 |
| 2024-04-29 | 40.5 | 2024-02-23 | 41.1 |
| 2024-04-26 | 40.8 | 2024-02-22 | 41.3 |
| 2024-04-25 | 41.1 | 2024-02-21 | 41.1 |
| 2024-04-24 | 40.8 | 2024-02-20 | 42.2 |
| 2024-04-23 | 41.0 | 2024-02-19 | 41.9 |
| 2024-04-22 | 41.3 | 2024-02-16 | 44.0 |
| 2024-04-19 | 41.0 | 2024-02-09 | 44.0 |
| 2024-04-18 | 40.2 | 2024-02-08 | 44.0 |
| 2024-04-17 | 40.6 | 2024-02-07 | 43.9 |
| 2024-04-16 | 39.9 | 2024-02-06 | 41.8 |
| 2024-04-15 | 40.8 | 2024-02-05 | 38.3 |
| 2024-04-12 | 39.1 | 2024-02-02 | 38.0 |
| 2024-04-11 | 36.9 | 2024-02-01 | 39.0 |
| 2024-04-10 | 37.1 | 2024-01-31 | 39.4 |
| 2024-04-09 | 37.8 | 2024-01-30 | 40.7 |
| 2024-04-08 | 37.5 | 2024-01-29 | 41.5 |
Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Beijing Tiantan Biological Products Corp Ltd
NAICS : 325414
ISIN : CNE000000WF9
Share Class Description:
SHSE:600161: Class ACompare
Compare
Traded in other countries / regions
600161.China IPO Date
1998-06-16Description
Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers